GlassScriptPhysician profile
Andrew W Warner
NPI 1215967880
$8,054.50
in general payments reported to CMS, 2019-2025
42 companies · $1,522 in 2025
The $1,522 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $479 · 2021: $1,429 · 2022: $885 · 2023: $1,172 · 2024: $1,397 · 2025: $1,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,083 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,083.32 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $924.33 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $845.32 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $800.86 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $773.66 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $516.17 | 2019-2025 | |
| Abbott Laboratories | $416.95 | 2019-2025 | Freestyle Libre 3 |
| Abbvie INC. | $399.21 | 2019-2025 | Ubrelvy |
| Glaxosmithkline, LLC. | $362.62 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $296.19 | 2019-2025 | Repatha, Otezla, Repatha |
| Exact Sciences Corporation | $266.53 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $239.60 | 2021-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $216.73 | 2019-2024 | |
| Eisai INC. | $188.67 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $178.33 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Amarin Pharma, INC. | $175.78 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.